...
首页> 外文期刊>Urologic oncology >Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancer?
【24h】

Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancer?

机译:在预测临床局限性前列腺癌的病理分期时,过渡区的PSA密度和PSA密度是否比PSA更准确?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To assess whether PSA density (PSAD) and PSA density of the transition zone (PSADTZ) are more accurate than PSA alone in predicting the pathological stage of prostate cancer. MATERIALS AND METHODS: One hundred and nine consecutive patients with clinically localized prostate cancer and preoperative PSA values over the whole range, treated with radical retropubic prostatectomy and limited pelvic lymph node dissection were included in this prospective study. Total prostate and transition zone volumes were measured by transrectal ultrasound using the prolate ellipsoid method. PSA, PSAD, and PSADTZ were compared to percentage of positive biopsy cores (% PC), biopsy and surgical Gleason score, and pathological stage, using univariate and multivariate analysis. RESULTS: Pathological stage was pT2a, pT2b, pT3a, and pT3b in 25.6%, 37.7%, 25.6%, and 11.1% of patients, respectively. Lymph node metastases were found in 4.6% of patients. PSA, PSAD, and PSADTZ were significantly related to % PC, biopsy, and surgical Gleason score and pathological stage (P < 0.001), and were equally able to predict higher pathological stage, i.e., seminal vesicle invasion and lymph node metastases. Only by adding % PC in multivariate analysis was it possible to discriminate intra- from extracapsular tumors. CONCLUSIONS: The results of the present study demonstrate that PSAD and PSADTZ failed to outperform PSA in preoperative stage prediction of prostate cancer, possibly because the formula used to calculate them does not eliminate the contribution to total PSA of the nonmalignant portion of the gland.
机译:目的:评估PSA密度(PSAD)和过渡区的PSA密度(PSADTZ)是否比单独PSA更准确地预测前列腺癌的病理阶段。材料与方法:这项前瞻性研究包括了一百零九名连续性临床局限性前列腺癌且术前PSA值在整个范围内,经根治性耻骨后前列腺切除术和有限的盆腔淋巴结清扫术治疗的患者。前列腺和过渡区的总体积是使用扁椭圆体经直肠超声测量的。使用单变量和多变量分析,将PSA,PSAD和PSADTZ与阳性活检核心百分比(%PC),活检和手术Gleason评分以及病理分期进行比较。结果:病理分期分别为pT2a,pT2b,pT3a和pT3b,分别占25.6%,37.7%,25.6%和11.1%的患者。在4.6%的患者中发现淋巴结转移。 PSA,PSAD和PSADTZ与PC百分比,活检以及手术Gleason评分和病理分期显着相关(P <0.001),并且同样能够预测更高的病理分期,即精囊侵犯和淋巴结转移。只有在多变量分析中添加%PC才有可能区分囊内肿瘤与囊外肿瘤。结论:本研究结果表明PSAD和PSADTZ在前列腺癌的术前预测中不能胜过PSA,这可能是因为用于计算它们的公式并未消除腺体非恶性部分对总PSA的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号